FRI0386 Efficacy and Safety of Off-Label Use of Rituximab in Refractory Lupus: Data from the Italian Multicenter Registry

L Iaccarino,M Galeazzi,R Gerli,S De Vita,D Roccatello,G Moroni,M Govoni,G Ferraccioli,G Valesini,A Doria,M Mosca,A Tincani

doi:10.1136/annrheumdis-2014-eular.2507

FRI0386 Efficacy and Safety of Off-Label Use of Rituximab in Refractory Lupus: Data from the Italian Multicenter Registry

L Iaccarino, M Galeazzi + Show 10 more

https://doi.org/10.1136/annrheumdis-2014-eular.2507

Copy DOI

Journal: Annals of the Rheumatic Diseases	Publication Date: Jun 1, 2014
Citations: 1

Affiliation: University of Padua, University of Perugia, Torino e-district, Ospedale Maggiore, University of Ferrara, Università Cattolica del Sacro Cuore, Sapienza University of Rome, University of Pisa, Brescia University, University of Brescia

#European Consensus Lupus Activity Measurement #Systemic Lupus Erythematosus + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

BackgroundDespite the failure of two randomized controlled trials a number of open-label studies and registries suggested the efficacy of rituximab (RTX) in systemic lupus erythematosus (SLE).ObjectivesThe aim of this observational...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of the Rheumatic Diseases

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.